title: Carcinoid tumour management in haemodialysis: a case report.
authors.forename: Michael T
authors.initials: MT
authors.lastname: Burke
authors.forename: Nicholas A
authors.initials: NA
authors.lastname: Gray
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002276:Carcinoid Tumor / Q000150:complications / Q000556:secondary / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D004334:Drug Administration Schedule; D006801:Humans; D007078:Ileal Neoplasms / Q000473:pathology / Q000628:therapy*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D008113:Liver Neoplasms / Q000150:complications / Q000556:secondary / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage* / Q000493:pharmacokinetics; D010456:Peptides, Cyclic / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006435:Renal Dialysis; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D015282:Octreotide